Get the Stockscreener App
883.20
0.84%
-7.48
After Hours:
883.20
Regeneron Pharmaceuticals, Inc. Stock (REGN) Forecast
The Regeneron Pharmaceuticals, Inc. (REGN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $878.76, representing a -0.50% decrease from the current price of $883.20. The highest analyst price target is $906.05, and the lowest is $851.46.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month REGN Price Target
Average 979.29
(+10.88% Upside)
Is Regeneron Pharmaceuticals, Inc. (REGN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 28.89 | Buy |
| STOCH(9,6) | 29.13 | Neutral |
| STOCHRSI(14) | 23.17 | Neutral |
| MACD(12,26) | -16.77 | Sell |
| ADX(14) | 23.40 | Neutral |
| William %R | -89.22 | Buy |
| CCI(14) | -154.52 | Sell |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
897.26
Sell
|
901.15
Sell
|
| MA20 |
918.54
Sell
|
914.85
Sell
|
| MA50 |
947.85
Sell
|
929.60
Sell
|
| MA100 |
925.81
Sell
|
915.55
Sell
|
| MA200 |
863.98
Buy
|
876.44
Buy
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, REGN could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 10 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on REGN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 28.89 indicates that REGN is oversold. This indicates that REGN price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 29.13 indicates that REGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 23.17 indicates that REGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 23.4 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -154.52 indicates that REGN is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term REGN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Regeneron Pharmaceuticals, Inc. financial reports and earnings history, Regeneron Pharmaceuticals, Inc. (REGN) stock could reach $1,401.31 by 2030, $3,872.17 by 2040 and $4,985.23 by 2050. See the projected annual prices until 2050 of the Regeneron Pharmaceuticals, Inc. stock below:
- Regeneron Pharmaceuticals, Inc. (REGN) is expected to reach an average price of $2,953.30 in 2035, with a high prediction of $3,023.50 and a low estimate of $2,947.31. This indicates an $234.39% rise from the last recorded price of $883.20.
- Regeneron Pharmaceuticals, Inc. (REGN) stock is projected to chart a bullish course in 2040, with an average price target of $3,868.17, representing an $337.97% surge from its current level. The forecast ranges from a conservative $3,767.38 to a sky-high $3,872.17.
- Our analysts predict Regeneron Pharmaceuticals, Inc. (REGN) to jump 392.90% by 2045, soaring from $4,307.50 to an average price of $4,353.26, potentially reaching $4,407.55. While $4,307.50 is the low estimate, the potential upside is significant.
- Regeneron Pharmaceuticals, Inc. (REGN) stock is expected to climb by 2050, reaching an average of $4,973.19, a $463.09% jump from its current level. However, a wide range of estimates exists, with high and low targets of $4,985.23 and $4,909.42, respectively, highlighting the market's uncertainty.
Regeneron Pharmaceuticals, Inc. Stock (REGN) Year by Year Forecast
Regeneron Pharmaceuticals, Inc. Stock (REGN) Price Forecast for 2024
Our forecast for REGN stock price in 2024 now indicates an average price target of $889.10 with a high forecast of $949.17 and a low forecast of $829.02. The average prediction reflects an increase of +0.67% from the last recorded price of $883.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2024 | $862.33 | $851.46 | $906.05 | -2.36% |
| June, 2024 | $836.25 | $829.02 | $872.67 | -5.32% |
| July, 2024 | $852.64 | $833.06 | $866.58 | -3.46% |
| August, 2024 | $860.26 | $835.95 | $869.07 | -2.60% |
| September, 2024 | $854.12 | $845.15 | $870.49 | -3.29% |
| October, 2024 | $846.30 | $841.01 | $872.49 | -4.18% |
| November, 2024 | $883.43 | $849.34 | $892.46 | +0.03% |
| December, 2024 | $937.76 | $879.33 | $942.99 | +6.18% |
Regeneron Pharmaceuticals, Inc. Stock (REGN) Price Forecast for 2025
Regeneron Pharmaceuticals, Inc. Stock (REGN) is expected to reach an average price of $1,138.19 in 2025, with a high prediction of $1,343.59 and a low estimate of $932.79. This indicates an +28.87% rise from the last recorded price of $883.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $978.93 | $932.79 | $983.90 | +10.84% |
| February, 2025 | $979.93 | $966.94 | $989.24 | +10.95% |
| March, 2025 | $1,010.86 | $946.95 | $1,015.65 | +14.45% |
| April, 2025 | $1,124.38 | $1,011.19 | $1,129.56 | +27.31% |
| May, 2025 | $1,119.62 | $1,050.43 | $1,151.86 | +26.77% |
| June, 2025 | $1,174.77 | $1,116.75 | $1,221.06 | +33.01% |
| July, 2025 | $1,226.70 | $1,165.58 | $1,241.02 | +38.89% |
| August, 2025 | $1,310.42 | $1,181.64 | $1,312.39 | +48.37% |
| September, 2025 | $1,320.86 | $1,267.40 | $1,330.41 | +49.55% |
| October, 2025 | $1,297.96 | $1,274.96 | $1,343.59 | +46.96% |
| November, 2025 | $1,274.34 | $1,258.48 | $1,328.19 | +44.29% |
| December, 2025 | $1,269.51 | $1,236.13 | $1,292.33 | +43.74% |
Regeneron Pharmaceuticals, Inc. Stock (REGN) Price Forecast for 2026
The predicted value for Regeneron Pharmaceuticals, Inc. (REGN) in 2026 is set at an average of $1,111.37. Estimates vary from a peak of $1,502.99 to a trough of $719.74, indicating an +25.83% surge from the present price of $883.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $1,256.86 | $1,246.53 | $1,326.83 | +42.31% |
| February, 2026 | $1,235.94 | $719.74 | $1,312.25 | +39.94% |
| March, 2026 | $1,221.56 | $1,199.91 | $1,251.47 | +38.31% |
| April, 2026 | $1,279.00 | $1,203.92 | $1,287.94 | +44.81% |
| May, 2026 | $1,220.17 | $1,220.07 | $1,302.27 | +38.15% |
| June, 2026 | $1,237.45 | $1,195.10 | $1,256.10 | +40.11% |
| July, 2026 | $1,271.73 | $1,232.05 | $1,276.00 | +43.99% |
| August, 2026 | $1,286.59 | $1,253.93 | $1,305.83 | +45.67% |
| September, 2026 | $1,326.37 | $1,274.14 | $1,330.87 | +50.18% |
| October, 2026 | $1,377.44 | $1,313.89 | $1,387.99 | +55.96% |
| November, 2026 | $1,432.57 | $1,368.48 | $1,432.78 | +62.20% |
| December, 2026 | $1,495.94 | $1,424.99 | $1,502.99 | +69.38% |
Regeneron Pharmaceuticals, Inc. Stock (REGN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Regeneron Pharmaceuticals, Inc. (REGN) is $1,506.79, with a high forecast of $1,641.09 and a low forecast of $1,372.50. This indicates an +70.61% increase from the last price of $883.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $1,430.14 | $1,428.75 | $1,498.09 | +61.93% |
| February, 2027 | $1,405.92 | $1,372.50 | $1,406.55 | +59.19% |
| March, 2027 | $1,487.63 | $1,405.22 | $1,505.23 | +68.44% |
| April, 2027 | $1,472.15 | $1,468.07 | $1,526.73 | +66.68% |
| May, 2027 | $1,485.01 | $1,452.17 | $1,508.44 | +68.14% |
| June, 2027 | $1,510.60 | $1,466.02 | $1,517.19 | +71.04% |
| July, 2027 | $1,501.19 | $1,474.55 | $1,513.54 | +69.97% |
| August, 2027 | $1,586.35 | $1,491.94 | $1,599.58 | +79.61% |
| September, 2027 | $1,559.22 | $1,556.01 | $1,641.09 | +76.54% |
| October, 2027 | $1,601.50 | $1,502.16 | $1,608.32 | +81.33% |
| November, 2027 | $1,531.92 | $1,455.29 | $1,603.64 | +73.45% |
| December, 2027 | $1,535.56 | $1,504.63 | $1,550.35 | +73.86% |
Regeneron Pharmaceuticals, Inc. Stock (REGN) Price Forecast for 2028
In 2028, Regeneron Pharmaceuticals, Inc. (REGN) is projected to reach an average price of $1,677.20, with a high projection of $1,858.26 and a low estimate of $1,496.14. This indicates an +89.90% rise from the last price of $883.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1,557.12 | $1,496.14 | $1,591.28 | +76.30% |
| February, 2028 | $1,671.67 | $1,519.57 | $1,702.02 | +89.27% |
| March, 2028 | $1,678.30 | $1,629.65 | $1,704.93 | +90.03% |
| April, 2028 | $1,713.27 | $1,657.71 | $1,725.33 | +93.98% |
| May, 2028 | $1,726.96 | $1,668.74 | $1,738.45 | +95.53% |
| June, 2028 | $1,710.59 | $1,696.84 | $1,758.55 | +93.68% |
| July, 2028 | $1,737.41 | $1,658.29 | $1,742.86 | +96.72% |
| August, 2028 | $1,751.91 | $1,729.23 | $1,801.50 | +98.36% |
| September, 2028 | $1,758.76 | $1,749.47 | $1,797.04 | +99.14% |
| October, 2028 | $1,851.83 | $1,739.57 | $1,857.90 | +109.67% |
| November, 2028 | $1,775.44 | $1,771.20 | $1,858.26 | +101.02% |
| December, 2028 | $1,779.62 | $1,754.38 | $1,803.50 | +101.50% |
Regeneron Pharmaceuticals, Inc. Stock (REGN) Price Forecast for 2029
The 2029 price forecast for Regeneron Pharmaceuticals, Inc. Stock (REGN) is $1,646.99 on average, with a high prediction of $1,996.32 and a low estimate of $1,297.65. This represents an +86.48% increase from the previous price of $883.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $1,742.86 | $1,733.07 | $1,837.97 | +97.33% |
| February, 2029 | $1,800.91 | $1,741.08 | $1,808.64 | +103.91% |
| March, 2029 | $1,897.94 | $1,787.26 | $1,915.09 | +114.89% |
| April, 2029 | $1,903.16 | $1,882.16 | $1,916.43 | +115.48% |
| May, 2029 | $1,895.38 | $1,882.39 | $1,938.73 | +114.60% |
| June, 2029 | $1,894.44 | $1,858.25 | $1,935.75 | +114.50% |
| July, 2029 | $1,946.38 | $1,882.61 | $1,956.51 | +120.38% |
| August, 2029 | $1,336.31 | $1,297.65 | $1,996.32 | +51.30% |
| September, 2029 | $1,398.28 | $1,333.12 | $1,401.98 | +58.32% |
| October, 2029 | $1,423.98 | $1,392.16 | $1,427.87 | +61.23% |
| November, 2029 | $1,432.03 | $1,413.93 | $1,456.35 | +62.14% |
| December, 2029 | $1,374.58 | $1,372.34 | $1,447.41 | +55.64% |
Regeneron Pharmaceuticals, Inc. Stock (REGN) Price Forecast for 2030
Regeneron Pharmaceuticals, Inc. Stock (REGN) is expected to reach an average price of $1,559.47 in 2030, with a high forecast of $1,759.13 and a low forecast of $1,359.81. This signifies an +76.57% surge from the last price of $883.20.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $1,368.90 | $1,368.64 | $1,401.31 | +54.99% |
| February, 2030 | $1,381.22 | $1,359.81 | $1,387.31 | +56.39% |
| March, 2030 | $1,398.47 | $1,381.08 | $1,412.41 | +58.34% |
| April, 2030 | $1,418.21 | $1,383.92 | $1,427.05 | +60.58% |
| May, 2030 | $1,419.26 | $1,410.29 | $1,428.56 | +60.70% |
| June, 2030 | $1,420.03 | $1,410.45 | $1,446.22 | +60.78% |
| July, 2030 | $1,475.49 | $1,425.23 | $1,476.95 | +67.06% |
| August, 2030 | $1,530.82 | $1,476.46 | $1,536.05 | +73.33% |
| September, 2030 | $1,583.14 | $1,528.00 | $1,585.55 | +79.25% |
| October, 2030 | $1,605.49 | $1,582.89 | $1,611.31 | +81.78% |
| November, 2030 | $1,631.84 | $1,565.78 | $1,636.63 | +84.76% |
| December, 2030 | $1,716.57 | $1,634.31 | $1,759.13 | +94.36% |
0.06%
1.69%
Cap:
|
Volume (24h):